Stocks and Investing
Stocks and Investing
Thu, April 29, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Wed, April 28, 2021
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Kennen MacKay Maintained (AMGN) at Hold with Decreased Target to $217 on, Apr 28th, 2021
Kennen MacKay of RBC Capital, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $220 to $217 on, Apr 28th, 2021.
Kennen has made no other calls on AMGN in the last 4 months.
There are 5 other peers that have a rating on AMGN. Out of the 5 peers that are also analyzing AMGN, 1 agrees with Kennen's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $230 on, Friday, March 5th, 2021
These are the ratings of the 4 analyists that currently disagree with Kennen
- Jay Olson of "Oppenheimer" Maintained at Buy with Increased Target to $275 on, Monday, April 5th, 2021
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $260 on, Wednesday, February 3rd, 2021
- Evan Seigerman of "Credit Suisse" Maintained at Buy with Decreased Target to $265 on, Wednesday, February 3rd, 2021
- Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $295 on, Wednesday, February 3rd, 2021
Contributing Sources